We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Single Laparoscopic Approach Favored for Common Bile Duct Stones

By HospiMedica International staff writers
Posted on 12 Feb 2010
A new study recommends that for common bile duct stones, a single laparoscopic procedure combining cholecystectomy with bile duct exploration is the best option.

Researchers at the University of California, San Francisco (UCSF; USA) conducted a prospective trial and randomized 122 patients to either a combined laparoscopic cholecystectomy with a laparoscopic common bile duct exploration (LC+LCBDE) or to separate endoscopic retrograde cholangiopancreatography sphincterotomy plus laparoscopic cholecystectomy (ERCP/S+LC). More...
The primary outcome measure was efficacy of stone clearance from the common bile duct; secondary end points were length of hospital stay, cost of index hospitalization, professional fees, hospital charges, morbidity and mortality, patient acceptance, and quality of life (QOL) scores.

The results showed that the primary outcome--total common bile duct stone clearance rates--did not differ significantly between the two approaches: 98% with ERCP/S+LC and 88% with LC+LCBDE. However, the mean time from the first procedure to hospital discharge was 55 hours in the LCBDE group, significantly shorter than the average 98 hours in the ERCP group. There were no major complications and only a few minor complications in each group. There were no significant differences between the groups in patient acceptance or QOL scores. The study was published in the January 2010 issue of Archives of Surgery.

"Laparoscopic CBDE eliminates the potential risks of ERCP-associated pancreatitis and the need for another procedure and the associated risks of anesthesia,” concluded lead author Stanley Rogers, M.D. and colleagues of the department of surgery. "As surgical skill with laparoscopic exploration of the common bile duct increases, the need for routine preoperative ERCP will likely decrease, except in unique high-risk situations.”

The researchers also found that both hospital service, professional charges, and total charges for patient hospitalization and were likewise lower for LC+LCBDE, but that the differences were not statistically significant.

Related Links:

University of California, San Francisco



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.